Developing improved therapies for cytomegalovirus infections by overcoming viral strain diversity.

巨细胞病毒感染是新生儿感染相关疾病最常见的原因，也是移植患者最常见的并发症之一。目前的治疗方法并不总是成功的，而且与显著的副作用相关。因此，我们已经开发了世界上第一个可以用来开发这种威胁生命的感染的更安全、更有效的治疗方法的系统。我们的发现可能也适用于其他难以管理的病毒感染。

Cytomegalovirus infection is the most common cause of infection-related disease in newborns and is one of the most common complications in transplant patients. Current treatments are not always successful and are associated with significant side-effects. We have therefore developed world first systems that can be used to develop safer, more effective treatments for this life-threatening infection. Our findings are likely to be applicable to other difficult to manage viral infections.